Ligand validation:6JWQ

AMP: ADENOSINE MONOPHOSPHATE

AMP is a Ligand Of Interest in 6JWQ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6JWQ_AMP_B_801	61%	38%	0.124	0.912	0.95	1.47	1	2	0	0	100%	1
6JWR_AMP_A_802	62%	35%	0.137	0.93	1.15	1.42	2	4	0	0	100%	1
6JWT_AMP_A_801	62%	63%	0.141	0.933	0.63	0.79	-	1	0	0	100%	1
6JWU_AMP_A_804	55%	61%	0.188	0.956	0.64	0.86	-	1	0	0	100%	1
6JWX_AMP_A_803	53%	36%	0.156	0.918	1.12	1.4	2	4	0	0	100%	1
6JWZ_AMP_A_803	52%	38%	0.178	0.936	1.04	1.38	2	2	0	0	100%	1
3LOQ_AMP_A_271	100%	45%	0.039	0.987	0.82	1.3	-	2	2	0	100%	1
7SNB_AMP_A_303	100%	55%	0.045	0.993	0.75	0.98	-	1	0	0	100%	0.783
4RDH_AMP_C_301	100%	23%	0.039	0.983	1.37	1.79	3	6	0	0	100%	1
3CLT_AMP_C_1262	100%	40%	0.046	0.987	0.91	1.4	1	4	0	0	100%	1
5VEO_AMP_A_524	100%	40%	0.046	0.987	0.86	1.47	-	3	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.